Half-Life

The time required for the concentration of a drug or peptide in the bloodstream to decrease by 50%. Half-life determines dosing frequency: longer half-life peptides like semaglutide (~7 days) require less frequent injection than short-acting peptides.

What does Half-Life mean in peptide research?

The time required for the concentration of a drug or peptide in the bloodstream to decrease by 50%. Half-life determines dosing frequency: longer half-life peptides like semaglutide (~7 days) require less frequent injection than short-acting peptides. This term is part of the broader field of peptide research, which encompasses both FDA-approved therapeutic peptides and research-grade compounds used in scientific investigation.

Why this term matters

Understanding Half-Life is foundational for anyone reviewing peptide research literature, comparing different research compounds, or following regulatory developments in this field. The term appears across pharmacology textbooks, FDA documentation, and clinical trial reports.

Where to learn more

For deeper context, see our peptide research articles:

• What Are Peptides? Comprehensive Introduction
• Research-grade vs Clinical-grade Peptides
• FDA Peptide Regulatory Status 2026
• Full Peptide Glossary Article